Efficacy and safety of onabotulinumtoxinA in the treatment of medication overuse headache: a systematic review

PurposeMedication overuse headache (MOH) is a chronic headache caused by regular overuse of medications. OnabotulinumtoxinA (BoNTA) is used for preventive treatment of MOH. However, its efficacy and safety remain controversial.MethodsSeven online databases (Cochrane Library, Embase, Medline, PubMed,...

Full description

Bibliographic Details
Published in:	Frontiers in Neurology
Main Authors:	Hui Lang, Cheng Peng, Kongyuan Wu, Xiwen Chen, Xin Jiang, Li He, Ning Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	medication overuse headache onabotulinumtoxinA systematic review headache treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1453183/full

Similar Items

A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
by: Licia Grazzi, et al.
Published: (2023-01-01)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
by: Carlo Baraldi, et al.
Published: (2023-01-01)

Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
by: Sebastian Worsaae Dalby, et al.
Published: (2024-02-01)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
by: Simona Guerzoni, et al.
Published: (2017-11-01)

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
by: Manjit Matharu, et al.
Published: (2017-08-01)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
by: Simona Guerzoni, et al.
Published: (2018-08-01)

OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
by: Ho-Tin Wong, et al.
Published: (2020-10-01)

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
by: Catherine Stark, et al.
Published: (2019-07-01)

OnabotulinumtoxinA for the treatment of headache: an updated review
by: Joseph H. Talbet, et al.
Published: (2022-01-01)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
by: Amanda Hansson-Hedblom, et al.
Published: (2020-08-01)

Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica
by: S. Santos-Lasaosa, et al.
Published: (2020-10-01)

The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability
by: Dilara Onan, et al.
Published: (2023-12-01)

Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic Migraine
by: Laura Gómez-Dabó, et al.
Published: (2024-05-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

Results of treating Patients with Chronic Migraine with OnabotulinumtoxinA alone Versus Its Combination with Other Prophylactic Drugs
by: Saber Abdelrohman, et al.
Published: (2022-04-01)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
by: Katarzyna Kępczyńska, et al.
Published: (2022-09-01)

A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
by: Srdjan Ljubisavljevic, et al.
Published: (2023-10-01)

Medication-Overuse Headache: Update on Management
by: Prut Koonalintip, et al.
Published: (2024-09-01)

Comparative efficacy and safety of different pharmacological therapies to medication overuse headache: a network meta-analysis
by: Fanyi Kong, et al.
Published: (2024-10-01)

Prediction models for identifying medication overuse or medication overuse headache in migraine patients: a systematic review
by: Teerapong Aramruang, et al.
Published: (2024-10-01)

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
by: Kwang Jin Ko, et al.
Published: (2023-05-01)

Medication-overuse headache: a widely recognized entity amidst ongoing debate
by: Nicolas Vandenbussche, et al.
Published: (2018-07-01)

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
by: Aubrey Manack Adams, et al.
Published: (2023-08-01)

Exploring Emotional Distress, Psychological Traits and Attitudes in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylaxis versus Withdrawal Treatment
by: Valeria Donisi, et al.
Published: (2020-09-01)

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
by: Andrew M. Blumenfeld, et al.
Published: (2018-02-01)

Treatment with OnabotulinumtoxinA for Oromandibular Dystonia: A Systematic Review and Meta-Analysis
by: Kazuya Yoshida, et al.
Published: (2024-12-01)

The Nursing Role in the Management of Medication Overuse Headache: Realities and Prospects
by: Luigi Alberto Pini, et al.
Published: (2024-06-01)

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
by: Marta Torres-Ferrus, et al.
Published: (2020-07-01)

Urinary tract infections in the intradetrusor onabotulinumtoxinA population
by: Esme White, et al.
Published: (2023-04-01)

Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication‐Overuse Headache
by: Gülcan Taşçatan, et al.
Published: (2025-03-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01)

Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
by: Dilara Onan, et al.
Published: (2024-07-01)

Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study
by: Shigeomi Iimura, et al.
Published: (2023-09-01)

Medication overuse headache: a review of current evidence and management strategies
by: Yabets Tesfaye Kebede, et al.
Published: (2023-08-01)

Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
by: María Pilar Navarro-Pérez, et al.
Published: (2024-06-01)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
by: Hans-Christoph Diener, et al.
Published: (2022-08-01)

Medication-overuse headache. Retrospective comparison of preventive treatments
by: Abouch V. Krymchantowski, et al.

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
by: Laura M. Tellechea, et al.
Published: (2022-09-01)

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
by: Larry Charleston, et al.
Published: (2023-08-01)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
by: Dilara Onan, et al.
Published: (2022-12-01)